Tenaya Therapeutics, Inc. (TNYA)

0.6947 0.00 (0.00%) USD  |  NASDAQ  |  Sep 03, 16:00
0.6947 0.00 (0.00%) After-Hours: 20:00
More

Tenaya Therapeutics Cash from Operations (Annual) : -68.26M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for TNYA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 -68.26M
December 31, 2024 -90.50M
December 31, 2023 -102.07M
December 31, 2022 -104.42M
Date Value
December 31, 2021 -60.81M
December 31, 2020 -35.45M
December 31, 2019 -24.10M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Intellia Therapeutics, Inc. -394.74M
Arrowhead Pharmaceuticals, Inc. 179.55M
Oncolytics Biotech, Inc. -20.11M
Sangamo Therapeutics, Inc. -97.21M
Sarepta Therapeutics, Inc. -222.54M